Maryland Oncology Hematology is a guest on Great Day Washington

Dr. Surupa Sen Gupta and Dr. Colette Magnant represented Maryland Oncology Hematology on Great Day Washington to explain the importance of screenings, self-exams, and living a healthy lifestyle for breast cancer awareness month.

 

Facebooktwitterlinkedinmail

Stop Breast Cancer For Life

As we approach breast cancer awareness month tomorrow Maryland Oncology Hematology is proud to be partnering with Lifetime and The Breast Cancer Research Foundation for their 27th year of “Stop Breast Cancer for Life.”

Our lives have changed, but what hasn’t is our fight against breast cancer. Lifetime has proudly supported breast cancer research for over 25 years. Get information on mammograms during COVID-19, read personal breast cancer stories, watch thriver videos, find resources, and more with our features below. Link: https://www.mylifetime.com/stop-breast-cancer-for-life

 

 

Facebooktwitterlinkedinmail

Do I need to get a COVID-19 vaccine booster?

As of Friday August 13th, the CDC is now recommending that people with moderate to severe compromised immune systems should receive an additional dose (booster) of the COVID-19 vaccine after the initial two-dose vaccine series. At MOH, many of our patients have moderately to severely compromised immune systems and do not always build the same level of immunity compared to people with normal immune systems.  The CDC recommendation identifies people with a range of conditions including:

  • Those receiving active cancer treatment for tumors or cancers of the blood
  • Those that have had a bone marrow or stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
  • Those with advanced or untreated HIV infection
  • Those actively being treated with high-dose corticosteroids or other drugs that may suppress your immune response

 

A full list of conditions can be found on CDC’s website.

 

Frequently Asked Questions (FAQs)

 

  1. Can you mix and match the vaccine type?

For people who received either Pfizer or Moderna’s COVID-19 vaccine series, a 3rd dose of the SAME mRNA vaccine should be used at least 4 weeks after completing the two-dose vaccine series.   A person should not receive more than three mRNA vaccine doses.

 

  1. What should immunocompromised people who received the J&J vaccine do?

The FDA’s & CDC’s recent amendment only applies to mRNA COVID-19 vaccines from Pfizer and Moderna.  There is not enough data at this time to determine whether immunocompromised people who received the J&J vaccine also have an improved antibody response following an additional dose of the same vaccine.

 

  1. Do I need a letter from my doctor in order to get the vaccine? 

At this time you do not need a letter from your physician in order to get the COVID-19 booster.  You will be able to self-attest that you meet criteria.

 

  1. If I am immunocompromised and I get the booster, can I stop wearing a mask?

While the Delta variant is surging, an additional vaccine dose for some people with weakened immune systems could help prevent serious and possibly life-threatening COVID-19 cases within this population.  Even after vaccination, people who are immunocompromised should continue follow current prevention measures (including wearing a mask, staying 6 feet apart from others they do not live with, and avoiding crowds and poorly ventilated indoor spaces) to protect themselves and those around them against COVID-19 until advised by your provider .

Facebooktwitterlinkedinmail

Maryland Oncology Hematology Gives New Meaning to Personalized Cancer Care

A Partnership Between Physicians and Their Community

Maryland Oncology Hematology believes in providing patients with advanced, comprehensive cancer therapies in a community setting that allows patients to receive care near their support systems. Our highly trained and experienced physicians work closely with a talented clinical team that is sensitive to the needs of cancer patients and their caregivers. Choosing an independent practice offers patients the chance to receive compassionate, affordable cancer care that utilizes the latest technologies provided by top physicians who are experts in their field. The best of care, close to home.

Patients can be assured that as an independent practice, MOH physicians are able to send patients to the best specialists or make recommendations based on specific care needs. We are never beholden to a practice or network. Unlike some of the major hospitals, our doctors are focused solely on oncology, giving patients the expert care that they deserve. At Maryland Oncology Hematology, we believe that patients are more than a number. Each patient will have a dedicated care team by their side from diagnosis through treatment to recovery.

Maryland Oncology Hematology is a community-based practice, entirely owned and run by Maryland physicians. Our team is devoted to providing state-of-the-art patient care for hematology and oncology, working on behalf of our community for the benefit of patients.

 I’m excited to be part of this highly respected community-based private practice,” said Jason Taksey MD., medical oncologist and managing partner for new Annapolis location. “Maryland Oncology Hematology delivers state-of-the-art care and remarkable treatments in an outpatient center that is safe, modern, convenient, and responsive to patient feedback.”

Why Patients Trust MOH

  • Comprehensive care including new radiation oncology services offered at White Oak Cancer Center in Silver Spring
  • Top-Rated Breast and Colorectal Surgeons
  • Team of almost 50 physicians and more than 50 years of experience
  • Research and phase 1-3 drug trial participation
  • Convenient locations
  • Financial guidance
  • Support groups and education
  • Hospital affiliations

Choosing an Independent Cancer Provider

As an independent practice, Maryland Oncology Hematology is proud to offer patients increased access to integrated, evidence-based cancer care and clinical research throughout the communities of Maryland. When compared to oncology services at big hospitals, independent cancer centers are typically more conveniently located, more individualized, and more likely to offer all necessary services under one roof. Independent cancer centers are also more cost effective for patients.

At MOH, our state-of-the-art infusion centers offer a full range of chemotherapy services, laboratory testing, clinical trials, and support services, provided by people who have an unwavering commitment to achieving the best possible result.

Our providers also have the freedom to choose the best possible specialists and hospital services for our patients, as well as arranging referrals for additional consultation or specialty care when needed. We ensure that our patients receive the best care based on each person’s unique diagnosis and treatment needs.

Maryland Oncology Hematology is able to offer cutting edge and innovative clinical research trials without the delays that many hospitals face. In partnership with US Oncology Network, MOH is able to unite the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients. These independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes.

Benefits to Patients

At Maryland Oncology Hematology, we strive to help patients through positive patient-doctor relationships while utilizing the latest in advanced technology. Other benefits include:

Better Access and Convenience

Community facilities offer integrated care close to home meaning there is less travel for patients. This provides reduced ER visits, admissions, and overnight hospital stays because of the proximity to care. At community cancer care clinics, patients receive treatments from one care team. In the hospital setting, patients are likely to see a different doctor and nurse throughout treatment.

Personalized Medicine

Our team utilizes a multidisciplinary approach to cancer care, combined with the most advanced treatments, cutting-edge technologies, and clinical trials research program. This includes precision medicine based on the genetic profile of a patient or their specific diseases. Molecular testing can be used to help target cancer treatments, as well as improve accuracy of a diagnosis in complex cases or help patients learn if there is a risk of cancer that runs in their families.

Immediate Appointments

At Maryland Oncology Hematology, we offer immediate appointments to newly referred patients, ensuring they get the care they need without stressful and unnecessary delays they might otherwise experience in major hospital systems. Our team will schedule a consult with one of our experts who can provide guidance and treatment options, as well as address any patient and family member concerns.

Community care offers patients:

  • Shorter wait times
  • Easily accessible surface parking and patient drop-offs
  • Less likelihood of catching infection associated with hospital visits
  • Access to support services, including social workers, financial assistance, and reimbursement specialists
  • Access to groundbreaking clinical trials
  • Lower cost of care across all cancer types when compared to hospital settings[1]

“We’re grateful to have the privilege to bring remarkable cancer care advances to our patients, as well as offer therapies that can improve their quality of life,” said Dr. Jason Taksey. “At MOH Annapolis, we are excited to offer superior care options for our patients and our surrounding community.”

 

About Maryland Oncology Hematology

 

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland with locations in Annapolis, Bethesda, Brandywine, Clinton, Columbia, Frederick, Germantown, Lanham, Laurel, Mt. Airy, Rockville and the White Oak Cancer Center in Silver Spring. Our more than 40 physicians are devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. For more information, visit MarylandOncology.com.

 

Media Contact

Company Name: Maryland Oncology Hematology

Contact Person: Mark W Lamplugh Jr

Email: Send Email

Phone: 5617629729

Country: United States

Website: https://mdoncology.wpengine.com

 

[1] https://ascopost.com/News/59474

Facebooktwitterlinkedinmail

Maryland Oncology Hematology Welcomes Colette Magnant, MD, FACS to Their Expanding Breast Surgical Oncology Team

Dr. Magnant joins Dr. Surupa Sen Gupta at their Rockville Division to offer the community advanced surgical care with the latest breast preservation techniques.

Maryland Oncology Hematology  (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, is proud to announce that Dr. Colette Magnant, MD, FACS is joining its Rockville division.

Dr. Magnant has been treating breast cancer for over 34 years and has established herself as one of the premier breast cancer surgeons in the Washington, D.C. metropolitan area.  With her extensive training and wealth of experience, she provides her patients with a superior understanding of breast cancer biology, as well as compassionate state of the art breast preservation procedures, and advanced surgical techniques. She will be joining Dr. Surupa Sen Gupta to expand our breast surgical oncology services at our Rockville division, and together they, along with our expert and experienced medical oncologists, will anchor our comprehensive breast cancer program in the Rockville division.

‘We’re thrilled to welcome Dr. Magnant  to our experienced breast surgical team. Her stellar reputation as a top breast surgeon is well-deserved and we are fortunate that she has decided to bring her skills to our practice and to our community.  She shares our vision of providing state-of-the-art multidisciplinary cancer care, and we are delighted to have her join in our expansion said George Sotos MD, Managing Partner, Rockville Division. ‘With her focus and strong surgical experience in breast cancer treatment, Dr. Magnant is a welcome addition to our team as we dedicate our practice to delivering the very best in comprehensive and integrated care to our breast cancer patients.

Dr. Magnant is board certified in general surgery, specializing in advanced breast surgery techniques, including skin and nipple-sparing mastectomies and minimally invasive breast conserving surgeries. After earning her medical degree from the Medical College of Virginia in Richmond, Dr. Magnant completed her general surgery internship at Indiana University Medical Center and her residency at Georgetown University Hospital in Washington, DC. She is most recently the past director of the Sullivan Center for Breast Health at Sibley Hospital, as well as an assistant professor at John Hopkins University. In addition to teaching, Dr. Magnant has made numerous media appearances and delivered dozens of university lectures.

‘I’m proud to work alongside the dynamic team at Maryland Oncology Hematology, said Dr. Magnant. ‘We’re dedicated to delivering compassionate and comprehensive breast health services to the surrounding community, allowing our patients to receive the best of care, close to home.

Dr. Magnant will be joining Dr. Sen Gupta who is board certified in general surgery, fellowship trained in breast surgical oncology, and specializes in minimally invasive breast-conserving surgeries.

Dr. Magnant will start seeing patients at MOH’s Rockville office on April 1st. Appointments are available for newly referred patients to provide a high level of support and easy access to care. Please call 301.424.6231 to make an appointment.

About Maryland Oncology Hematology

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.

About US Oncology Network

Maryland Oncology Hematology is a practice in The US Oncology Network  (The Network). This collaboration unites the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation , whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. MOH also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.

 

Media Contact
Company Name: Maryland Oncology Hematology
Contact Person: Mark W Lamplugh Jr
Email: Send Email
Phone: 5617629729
Country: United States
Website: https://mdoncology.wpengine.com

 

Facebooktwitterlinkedinmail

What are Complementary Therapies, and What Can They Do for Cancer Patients?

Complementary therapies are products and/or practices that differ from standard medical care provided by your oncologists. These non-traditional methods are in no way meant to replace cancer treatment. They’re called complementary because they are meant to work alongside your cancer treatment in hopes of relieving symptoms and side effects, relieving pain, and improving quality of life.

Complementary therapies typically concentrate on relaxation and reducing stress. Many of these types of therapies may help calm emotions, relieve anxiety, reduce nausea, minimize pain, provide extra energy, and increase overall health and well being.

Many cancer patients feel as though complementary therapies leave them with a little more control over their health as they go through cancer treatment. They also tend to appreciate that complementary therapies do not require additional medicines. When the symptoms and side effects of your cancer treatment are difficult to cope with, these alternative approaches can be supportive in bringing relief. Before adding any complementary therapy to your current treatment, however, it is important to talk with your cancer specialist.

There are many different types of complementary therapy. Be sure to tell your therapist or instructor that you are a cancer patient before you start any complementary therapy. This is important information that could impact what they recommend for you.

Complementary therapies include, but are not limited to:

  • Aromatherapy and Essential Oils: The use of essential oils either by inhalation or topical application. Oils can aid in reducing anxiety, nausea, depression, and pain. Be sure you receive instruction before applying any oils to your skin.
  • Acupuncture: The practice of applying needles, heat, pressure, and other treatments to one or more places on the skin known as acupuncture points. It can be effective for cancer treatment side effects such as nausea and vomiting, pain, and fatigue.
  • Chiropractic: A chiropractor can provide hands-on manipulation of the spine (adjustment) that can help with stresses cancer treatment has put on the musculoskeletal system, which can increase mobility, flexibility, strength, and function. It may also help relieve nausea, fatigue, headaches, and other body pains in the back and neck area.
  • Herbal supplements: May help strengthen the immune system and ease the side effects of cancer treatment. These can interact with medicines being used for cancer treatment and should always be discussed with your cancer care team before using.
  • Massage therapy: A hands-on method of manipulating the soft tissues of the body that can promote relaxation and help with pain, fatigue, immune function.
  • Guided Imagery (Visualization): A technique that focuses and directs the imagination toward a specific goal. Practicing this may be able to reduce feelings of depression and increase feelings of well-being. The University of Michigan provides a free guided imagery audio library.
  • Art or music therapy: Creative arts that promote a better quality of life by aiding in the reduction of depression, anxiety, and pain. It can also be a positive outlet for emotional expression.
  • Yoga: Yoga connects the mind and body through movement and meditation. Yoga can help improve quality of life by relieving both physical and emotional stress.
  • Support groups: Group meetings can help cancer patients cope. Having emotional support can help improve both quality of life and survival.

In most cases, cancer doctors are very supportive of their patients using complementary therapies. This is typically because they have seen people cope better with the cancer and its treatment.

Again, it isn’t recommended that complementary therapies replace cancer treatment. They are simply meant to be used in conjunction with the current cancer treatment. Talking with your cancer specialist can help find the right balance between the complementary therapies and traditional treatments you are receiving for your cancer. Our oncologist at Maryland Oncology Hematology are able to talk you through these complementary cancer therapies, as well as additional methods of therapy that may be best for your cancer care. If you are in Maryland or the Washington D.C. area, you can schedule a consultation by picking the Maryland Oncology Hematology location that’s most convenient to you and calling to make an appointment.

Sources:

Facebooktwitterlinkedinmail

Weather Update 2/19/2021

Check our 2/19/2021 weather update page for practice closures and operating hour changes for tomorrow. All recent updates will be added or changed as offices make decisions. If your office isn’t listed, then no changes have be made yet. Feel free to call your office with any questions regarding appointments. Check this page for updates throughout the evening and tomorrow.

Columbia office will be open normal business hours. 

Capital division which includes Silver Spring White Oak Cancer Center & Laurel will be open normal hours.

Our Southern division which includes Brandywine & Lanham will be open 1 hour late on 2/19/2021

Our Frederick division which included our Frederick & Mt Airy office will open at 10AM 2/19/2021

Rockville Division which includes Rockville – Aquilino Cancer Center, Germantown and Bethesda will be open at 10AM on  2/19/2021

 

Annapolis will open at 10AM on 2/19/2021 due to the weather.

Facebooktwitterlinkedinmail

Weather Update 2/2/2021

Due to weather our Frederick & Mt Airy offices will be opening 10AM on 2/2/2021. If you have questions regarding rescheduling, you can reach our Frederick office at 301-695-6777 and Mt Airy at 301-829-0707.

Mt Airy: https://mdoncology.wpengine.com/locations…/locations/mt-airy/

Frederick: https://mdoncology.wpengine.com/locatio…/locations/frederick/

Due to weather our Columbia office will be opening at 10:00AM with 2Hr delay. If you have questions regarding rescheduling, you can reach our Columbia office at 410-964-2212

Columbia: Columbia | Maryland Oncology Hematology

 

Due to weather our Rockville, Germantown and Bethesda offices will be opening 2 hr delay on 2/2/2021. If you have questions regarding rescheduling, please call your office at  301-424-6231

Rockville: Rockville – Aquilino Cancer Center | Maryland Oncology Hematology

Bethesda: Bethesda | Maryland Oncology Hematology

Germantown: Germantown | Maryland Oncology Hematology

All other offices are operating as usual.

Facebooktwitterlinkedinmail

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

United in Healing with The US Oncology Network - Maryland Oncology Hematology